Skip to main content
SpringerLink
Log in

Hepatobiliary Cancer

  • Chapter
What’s New in Surgical Oncology

  • 1307 Accesses

Abstract

Hepatobiliary surgery has had an extraordinary evolution in recent decades. In the 1970s, it was a high-risk procedure undertaken by few surgeons treating advanced diseases having a poor prognosis. To date, hepatobiliary surgery is a standardized procedure, carried out routinely, reaching near-zero mortality rates and offering a chance of cure to many cancer patients. Furthermore, the surgeon is no more the only “actor” in patient treatment. He/she has been inserted into a multidisciplinary setting in which his/her expertise is combined with that of oncologists, gastroenterologists, radiologists and radiotherapists to optimize management of patients. Hepatobiliary surgery is now considered a separate specialty undertaken by dedicated surgeons. Even if the centralization of hepato-biliary oncology and surgery has not yet been standardized, many data are in favor of this direction, and referral centers can be easily identified. We will try to depict the most important ad innovative data during recent years in hepatic and biliary surgical oncology. Solid evidences and new perspectives will be analyzed. Due to the unfeasibility of analyzing every issue, the most significant ones will be considered briefly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Llovet JM, Ducreux M, Lencioni R et al (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56: 908–943

    Article  Google Scholar 

  2. Torzilli G, Belghiti J, Kokudo N et al (2012) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centres: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC east-west study group. Ann Surg, in press

    Google Scholar 

  3. Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143: 469–475

    Article  PubMed  Google Scholar 

  4. Hasegawa K, Makuuchi M. Takayama T et al (2008) Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49: 589–594

    Article  PubMed  Google Scholar 

  5. Livraghi T, Meloni F, Di Stasi M et al (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47: 82–89

    Article  PubMed  Google Scholar 

  6. Zhou Y, Zhao Y, Li B, et al (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 10: 78

    Article  PubMed  Google Scholar 

  7. Cherqui D, Laurent A, Mocellin N et al (2009) Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 250(5): 738–746

    Article  PubMed  Google Scholar 

  8. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378–390

    Article  PubMed  CAS  Google Scholar 

  9. Sangro B, Iñarrairaegui M, Bilbao JI (2012) Radioembolization for hepatocellular carcinoma. J Hepatol.;56: 464–4

    Article  PubMed  Google Scholar 

  10. Adam R, De Gramont A, Figueras J et al (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17: 1225–1239

    Article  PubMed  CAS  Google Scholar 

  11. Viganò L, Russolillo N, Ferrero A, et al (2012) Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades. Ann Surg Oncol 19: 2035–2044

    Article  PubMed  Google Scholar 

  12. Viganò L, Langella S, Ferrero A et al (2012) Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol, in press

    Google Scholar 

  13. Floriani I, Torri V, Rulli E et al (2010). Performance of Imaging Modalities in Diagnosis of Liver Metastases From Colorectal Cancer: A Systematic Review and Meta-analysis J Magn Reson Imaging 31: 19–31

    Article  PubMed  Google Scholar 

  14. de Haas RJ, Wicherts DA, Flores E, et al (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248: 626–637

    PubMed  Google Scholar 

  15. Capussotti L, Muratore A, Mulas MM et al (2006). Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 93(8): 1001–6

    Article  PubMed  CAS  Google Scholar 

  16. Nordlinger B, Sorbye H, Glimelius B, et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): arandomised controlled trial. Lancet 371: 1007–1016

    Article  PubMed  CAS  Google Scholar 

  17. Viganò L, Capussotti L, Barroso E, et al (2012) Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol 19: 2786–2796

    Article  PubMed  Google Scholar 

  18. Rubbia-Brandt L,Giostra E, Brezault C et al (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18(2): 299–304

    Article  PubMed  CAS  Google Scholar 

  19. Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065–2072

    Article  PubMed  CAS  Google Scholar 

  20. Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24: 3939–3945

    Article  PubMed  Google Scholar 

  21. Hurwitz H, Fehrenbacher L,Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23): 2335–42

    Article  PubMed  CAS  Google Scholar 

  22. Loupakis F, Cremolini C, Salvatore L et al (2012) Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategies. Cancer 118(6): 1523–32

    Article  PubMed  CAS  Google Scholar 

  23. Jaeck D, Oussoultzoglou E, Rosso E et al (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240(6): 1037–49

    Article  PubMed  Google Scholar 

  24. Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3): 405–14

    Article  PubMed  Google Scholar 

  25. Andres A, Toso C, Adam R et al. A Survival Analysis of the Liver-First Reversed Management of Advanced Simultaneous Colorectal Liver Metastases: A LiverMetSurvey-Based Study. Ann Surg 256(5): 772–779

    Google Scholar 

  26. Cirocchi R, Trastulli S, Boselli C, Montedori et al (2012) Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev 13;6:CD006317

    Google Scholar 

  27. Ribero D, Pinna AD, Guglielmi A et al (2012). Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis of 434 Patients. Arch Surg 20: 1–7

    Google Scholar 

  28. Farges O, Fuks D, Boleslawski E et al (2011). Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 254(5): 824–29

    Article  PubMed  Google Scholar 

  29. Nagino M, Ebata T, Yokoyama Y et al (2012) Evolution of Surgical Treatment for Perihilar Cholangiocarcinoma: A Single-Center 34-Year Review of 574 Consecutive Resections. Ann Surg, in press

    Google Scholar 

  30. de Jong MC, Marques H, Clary BM et al (2012) The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer 118(19): 4737–47

    Article  PubMed  Google Scholar 

  31. Ribero D, Amisano M, Lo Tesoriere R et al (2011) Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg 254(5): 776–81

    Article  PubMed  Google Scholar 

  32. Neuhaus P, Thelen A, Jonas S et al (2012) Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 19(5): 1602–8

    Article  PubMed  Google Scholar 

  33. Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242(3): 451–8

    PubMed  Google Scholar 

  34. Nishio H, Ebata T, Yokoyama Y et al (2011) Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg 253(5): 953–60

    Article  PubMed  Google Scholar 

  35. Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14): 1273–81

    Article  PubMed  CAS  Google Scholar 

  36. Mirnezami R, Mirnezami AH, Chandrakumaran K et al (2011) Short-and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis. HPB 13(5): 295–308

    Article  PubMed  Google Scholar 

  37. Liu CL, Fan ST, Cheung ST et al (2006) Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg 244: 194–203

    Article  PubMed  Google Scholar 

  38. Capussotti L, Ferrero A, Russolillo N et al (2012) Routine anterior approach during right hepatectomy: results of a prospective randomised controlled trial. J Gastrointest Surg 16(7): 1324–1332

    Article  PubMed  Google Scholar 

  39. Giuliante F, Ardito F, Pulitano C et al (2010) Does hepatic pedicle clamping affect disease-free survival following liver resection for colorectal metastases? Ann Surg 252(6): 1020–1026

    Article  PubMed  Google Scholar 

  40. Ferrero A, Russolillo N, Viganò L et al (2010) Does Pringle maneuver affect survival in patients with colorectal liver metastases? World J Surg 34(10): 2418–2425

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HPB and Digestive surgery, Ospedale Mauriziano Umberto I, Turin, Italy

    Lorenzo Capussotti, Luca Viganò & Nadia Russolillo

Authors
  1. Lorenzo Capussotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Viganò
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadia Russolillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorenzo Capussotti .

Editor information

Editors and Affiliations

  1. General, Emergency and Minimally Invasive Surgery, Careggi Hospital, Florence, Italy

    Andrea Valeri , Carlo Bergamini  & Jacopo Martellucci ,  & 

  2. Local Healthcare Unit ULSS 19 - Veneto, Adria, Italy

    Ferdinando Agresta

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Capussotti, L., Viganò, L., Russolillo, N. (2013). Hepatobiliary Cancer. In: Valeri, A., Bergamini, C., Agresta, F., Martellucci, J. (eds) What’s New in Surgical Oncology. Springer, Milano. https://doi.org/10.1007/978-88-470-5310-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5310-6_5

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5309-0

  • Online ISBN: 978-88-470-5310-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation